Westchester Capital Management (New York)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Westchester Capital Management (New York)’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,685,423	Closed	-$66.3M	–	382
2023 Q2	$66.3M	Buy	+1,685,423	New	+$59.5M	2.08%	9

Westchester Capital Management (New York)'s ISEE Position: Q3 2023 in Review

Westchester Capital Management (New York) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,685,423 shares — an estimated $66.3M sold.

Westchester Capital Management (New York) first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $66.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Westchester Capital Management (New York) reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 1,685,423 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $66.3M.
Westchester Capital Management (New York) first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Westchester Capital Management (New York)'s IVERIC bio, Inc. Common Stock position peaked at $66.3M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2023, filed 8 Nov 2023.